<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-132637</identifier>
<setSpec>0212-1611</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">An exclusively based parenteral fish-oil emulsion reverses cholestasis</dc:title>
<dc:description xml:lang="en">Prolonged parenteral nutrition (PN) leads to liver damage. Recent interest has focused on the lipid component of PN. A lipid emulsion based on w-3 fatty acids decrease conjugated bilirubin. A mixed lipid emulsion derived from soybean, coconut, olive, and fish oils reverses jaundice. Here we report the reversal of cholestasis and the improvement of enteral feeding tolerance in 1 infant with intestinal failure-associated liver disease. Treatment involved the substitution of a mixed lipid emulsion with one containing primarily omega-3 fatty acids during 37 days. Growth and biochemical tests of liver function improved significantly. This suggests that fat emulsions made from fish oils may be more effective means of treating this condition compared with an intravenous lipid emulsion containing soybean oil, medium -chain triglycerides, olive oil, and fish oil (AU)</dc:description>
<dc:creator>Triana Junco, Miryam</dc:creator>
<dc:creator>Ybarra Zabala, Marta</dc:creator>
<dc:creator>García Vázquez, Natalia</dc:creator>
<dc:creator>Sáenz de Pipaón Marcos, Miguel</dc:creator>
<dc:creator>Abrams, Steven</dc:creator>
<dc:creator>Zozaya, Carlos</dc:creator>
<dc:creator>García de Lorenzo, Abelardo</dc:creator>
<dc:language>en</dc:language>
<dc:description xml:lang="es">La nutrición parenteral prolongada produce daño hepático. Recientemente se ha comunicado el efecto de las emulsiones lipídicas intravenosas basadas exclusivamente en ácidos grasos omega-3 en la resolución de la colestasis. Lo mismo se ha observado con el uso de emulsiones lipídicas mixta derivadas del aceite de soja, coco, oliva y pescado. Comunicamos la desaparición de colestasis y mejoría de la tolerancia enteral en un niño con enfermedad hepática asociada a nutrición parenteral. El tratamiento consistió en sustituir una emulsión lipídica mixta por otra que contenía de forma exclusiva aceite de pescado durante 37 días. El crecimiento y los datos bioquímicos de función hepática mejoraron de forma significativa. Este caso sugiere que emulsiones lipídicas intravenosas a partir de aceite de pescado pueden ser mas eficaces para tratar la colestasis si se comparan con emulsiones mixtas (AU)</dc:description>
<dc:source>Nutr Hosp;31(1): 514-516, ene. 2015.</dc:source>
<dc:identifier>ibc-132637</dc:identifier>
<dc:title xml:lang="es">Una emulsión lipídica basada exclusivamente en aceite de pescado revierte la colestasis</dc:title>
<dc:subject>^d30401</dc:subject>
<dc:subject>^d22453^s22000</dc:subject>
<dc:subject>^d5321^s22073</dc:subject>
<dc:subject>^d22453^s22073</dc:subject>
<dc:subject>^d19352^s22000</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d5321^s22000</dc:subject>
<dc:subject>^d24651^s22073</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d14679^s22062</dc:subject>
<dc:subject>^d33760^s22067</dc:subject>
<dc:subject>^d22226</dc:subject>
<dc:subject>^d2829^s22057</dc:subject>
<dc:subject>^d24651^s22000</dc:subject>
<dc:type>article</dc:type>
<dc:date>201501</dc:date>
</metadata>
</record>
</ibecs-document>
